How can molecular biology contribute to the management of congenital adrenal hyperplasia?

Hormone Research

Volumn 53, Issue SUPPL. 1, 2000, Pages 34-37

  Ritzén, E Martin ^a,b   Lajic, Svetlana ^a   Wedell, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

21 Hydroxylase deficiency; Genotype; Glucocorticoids; Phenotype; Prenatal treatment

Indexed keywords

ANDROGEN; ANTIANDROGEN; AROMATASE INHIBITOR; CORTICOSTEROID; GLUCOCORTICOID;

ADRENALECTOMY; ANDROGEN RELEASE; BONE DEMINERALIZATION; BONE GROWTH; CHILD; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; GENE MUTATION; GENOTYPE; HORMONAL REGULATION; HUMAN; MOLECULAR BIOLOGY; OBESITY; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY;

EID: 0033940727     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053202     Document Type: Conference Paper

References (19)

1. Wedell A, Thilén A, Ritzén EM, Stengler B, Luthman H: Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 1994;78:1145-1152.
2. Wilson RC, Mercado AB, Cheng KC, New MI: Steroid 21-hydroxylase deficiency: Genotype may not predict phenotype. J Clin Endocrinol Metab 1995;80:2322-2329.
3. Jääskeläinen J, Levo A, Voutilainen R, Partanen J: Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: Good correlation in a well defined population. J Clin Endocrinol Metab 1997;82: 3293-3297.
4. Nordenström A, Thilén A, Hagenfeldt L, Larsson A, Wedell A: Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999;84:1505-1509.
5. Thilén A, Woods KA, Perry LA, Savage MO, Wedell A, Ritzén M: Early growth is not increased in untreated moderately severe 21-hydroxylase deficiency. Acta Paediatr 1995;84: 894-898.
6. David M, Forest MG: Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 1984;105: 799-803.
7. Forest MG, Morel Y, David M: Prenatal treatment of congenital adrenal hyperplasia. Trends Endocrinol Metab 1998;9:284-289.
8. Miller WL: Prenatal treatment of congenital adrenal hyperplasia: A promising experimental procedure of unproven safety. Trends Endocrinol Metab 1998;9:290-293.
9. Ritzén EM: Prenatal treatment of congenital adrenal hyperplasia: A commentary. Trends Endocrinol Metab 1998;9:293-295.
10. Lajic S, Wedell A, Bui T-H, Ritzén EM, Holst M: Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1998;83:3872-3880.
11. Urban M, Peter L, Migeon C: Adult height and fertility in men with congenital virilising adrenal hyperplasia. N Engl J Med 1978;299:1392-1396.
12. Helleday J, Siwers B, Ritzén EM, Carlström K: Subnormal androgen and elevated progesterone levels in women treated for congenital virilising 21-hydroxylase deficiency. J Clin Endocrinol Metab 1993;76:933-936.
13. Girgis R, Winter JS: The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1997;82:3926-3929.
14. Jääskeläinen J, Voutilainen R: Growth of patients with 21-hydroxylase deficiency: An analysis of the factors influencing adult height. Pediatr Res 1997;40:30-33.
15. Van Wyk JJ, Gunther DF, Ritzén EM, Wedell A, Cutler GB Jr, Migeon CJ, New MI: The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1996;81:3180-3190.
16. Laue L, Merke DP, Jones JV, Barnes KM, Hill S, Cutler GB Jr: A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1996;81: 3535-3539.
17. Janoski AH: Naturally occurring adrenal steroids with salt-losing properties: Relationship to congenital adrenal hyperplasia; in Lee PA, Plotnick LP, Kowarski AA, Migeon CJ (eds): Congenital Adrenal Hyperplasia. Baltimore, University Park Press, 1977, pp 99-112.
18. Gunther DF, Bukowski TP, Ritzén EM, Wedell A, Van Wyk JJ: Prophylactic adrenalectomy of a three-year old girl with congenital adrenal hyperplasia: Pre-and postoperative studies. J Clin Endocrinol Metab 1997;82:3324-3327.
19. Hamberger B, Telenius-Berg M, Cedermark B, Gröndal S, Hansson BG, Werner S: Subtotal adrenalectomy in multiple endocrine neoplasia type 2. Henry Ford Hosp Med J 1987;35:127-128.